Inovio Pharmaceuticals, Inc.

8.14 USD
+0.21 (+2.65%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Inovio Pharmaceuticals, Inc. stock is down -1.93% since 30 days ago. The next earnings date is Mar 4, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 24 February’s closed higher than January. In the last 2 Unusual Options Trades, there were 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
15 Feb 18:08 17 Jan, 2025 10.00 PUT 100 0
16 Feb 14:36 17 Jan, 2025 5.00 PUT 200 53

About Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines. Its DNA medicines platform uses precisely designed SynCon that identifies and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.